期刊文献+

23G、25G联合经结膜免缝合微创玻璃体切割术治疗黄斑前膜 被引量:11

Therapeutic effects of combined with 23G and 25G micro-invasive vitrectomy for epiretinal membrane
下载PDF
导出
摘要 目的探讨23G、25G联合经结膜免缝合微创玻璃体切割术(transconjunctival sutureless vitrectomy,TSV)治疗黄斑前膜疗效。方法收集我院22眼应用23G、25G联合TSV治疗黄斑前膜的手术资料。对手术前后最佳矫正视力、光学相干断层扫描(optical coherence tomography,OCT)检查黄斑前膜进行对比分析。术后随访2~9个月,观察对比手术前后视力和OCT检查的黄斑中心凹厚度。结果所有手术均顺利完成,术后视力均明显提高,末次随访最佳矫正视力好于术前矫正视力,差异有统计学意义(P<0.05),其中术后视力提高0.15~0.2者6眼,提高0.1者12眼,提高0.05~0.1者4眼。末次随访时OCT显示术后黄斑中心凹厚度明显低于术前,差异有统计学意义(P<0.05)。结论 23G、25G联合TSV治疗黄斑前膜安全、有效。 Objective To evaluate the effect of 23-gauge and 25-gauge micro-invasive transconjunctival sutureless vitrectomy on epiretinal membrane.Methods Twenty-two eyes of epiretinal membrane surgery information underwent 23G and 25G transconjunctival sutureless vitrectomy were collected.The best corrected visual acuity and epiretinal membrane examined by optical coherence tomography(OCT) were analyzed before and after the surgery.The follow-up time was from 2 months to 9 months,and the preoperative and postoperative visual acuity and macular fovea thickness were observed.Results All procedures were uneventful.The postoperative visual acuity in all patients was improved and the postoperative best corrected visual acuity at the last follow-up time was better than pre-operation,there was statistical difference(P0.05),in which the visual acuity improved from 0.15 to 0.2 in 6 eyes,0.1 in 12 eyes and from 0.05 to 0.1 in 4 eyes,OCT at the last follow-up time showed the postoperative macular fovea thickness was significantly lower than pre-operation,the difference was statistically significant(P0.05).Conclusion Combined with 23G and 25G transconjunctival sutureless micro-invasive vitrectomy is safe and effective in treating the epiretinal membrane.
出处 《眼科新进展》 CAS 北大核心 2012年第3期253-256,共4页 Recent Advances in Ophthalmology
关键词 23G、25G经结膜免缝合微创玻璃体切割术 黄斑前膜 光学相干断层扫描 23G and 25G transconjunctival sutureless vitrectomy epiretinal membrane optical coherence tomography
  • 相关文献

参考文献16

  • 1陈钦元.黄斑部视网膜前膜[M]//聂爱光.现代黄斑疾病诊断治疗学.北京:北京医科大学、中国协和医科大学联合出版社,1996:131-135.
  • 2OpMalley C,Heintz RM Sr.Vitrectomy w ith an alternative instru-mentsystem[J].Ann Ophthalmol,1975,7(4):585-588,591-594.
  • 3Fujii GY,Dejuan E Jr,Humayun MS,Pieramici DJ,Chang TS,Aw h C,et al.A new25-gauge instrument system for transcon-junctival sutureless vitrectomy surgery[J].Ophthalmology,2002,109(10):1807-1812.
  • 4Marco M,Tan SH,De Smet MD.Use of25-gauge vitrectomy in the management of primary rhegmatomenous retinal detachment Retina-the journal of retinal and vitreous diseases[J].Retina,2009,29,(9):1299-1304.
  • 5Akaishi L,Canamary F,Tzelikis PF.Transconjunctival sutureless 25-gauge vitrectomy for visually significant vitreous floaters in patients w ith multifocal intraocular lens[J].Rev Bras Oftalmol,2010,69(4):252-258.
  • 6Boni S,Barale PO,Gendron G,Poisson F,Scheer S,Sahel JA.Surgery of the idiopathic epimacular membrane on transcon-junctival25-gauge vitrectomy(TSV):A series of50cases[J].J Fr Ophtalm ol,2010,33(8):544-550.
  • 7Eckardt C.Transconjunctival sutureless23-gauge vitrectomy[J].Retina,2005,25(2):208-211.
  • 8Kim MJ,Park KH,Hw ang JM,Yu HG,Yu YS,Chung H.The safe-ty and efficacy of transconjunctiva l sutureless23-gauge vitrec-tomy[J].Korean J Ophthalmol,2007,21(4):201-207.
  • 9Fine HF,Iranmanesh R,Iturralde D,Spaide RF.Outcomes of77consecutive cases of23-gauge transconjunctival vitrectomy sur-gery for posterior segment disease[J].Ophthalmology,2007,114(6):1197-1200.
  • 10Oliveira LB,Reis PA.Silicone oil tamponade in23-gauge transconjunctival sutureless vitrectomy[J].Retina,2007,27(8):1054-1058.

二级参考文献30

  • 1中华医学会眼科学会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42-42.
  • 2Kwok AK,Tham CC,Lam DS,et al.Modified sutureless sclerotomies in pars plana vitrectomy.Am J Ophthalmology,1999,127:731-732.
  • 3Rabman R,Rosen PH,Riddell C,et al.Selfsealing sclerotomies for sutrueless pars plana vitrectomy.Ophthalmic Surg Lasers,2000,31:462-466.
  • 4Hershberger VS,Augsburger JJ,Hutchins RK,et al.Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage:ultrasound biomicroscopy findings.Ophthalmology,2004,111:1215-1221.
  • 5Bhende M,Agraharam SG,Gopal L,et al.Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage.Ophthalmology,2000,107:1729-1736.
  • 6Eckardt C.Transconjunctival sutureless 23-gauge vitrectomy.Retina,2005,25:208-211.
  • 7Chen JC.Sutureless pars plana vitreetomy through selfsealing selerotomies.Arch Ophthalmol,1996,114:1273-1275.
  • 8Fujii GY,De Juan E Jr,Humayun MS,et al.A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery.Ophthalmology,2002,109:1807-1812.
  • 9Fujii GY,de Juan E,S Mark,et al.Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery.Ophthalmology,2002,109:1814-1820.
  • 10Kapran Z,Acar N.Removal of silicone oil with 25-gauge transconjunctival sutureless vitrectomy systerm.Retina,2007,27:1059-1064.

共引文献66

同被引文献126

  • 1张少冲,冷云霞,佘洁婷,李松峰.特发性黄斑前膜的手术效果及评价[J].中国实用眼科杂志,2005,23(8):825-827. 被引量:18
  • 2尹东明.视网膜复位术后黄斑前膜形成的早期药物治疗[J].眼外伤职业眼病杂志,2005,27(10):742-743. 被引量:2
  • 3陈光胜,马丽华.黄斑前膜的玻璃体手术疗效观察[J].广西医学,2006,28(4):531-533. 被引量:5
  • 4李洁,戴虹,夏群,龙力.对比敏感度对特发性黄斑前膜的视功能评价[J].眼科,2006,15(4):253-257. 被引量:6
  • 5陈钦元.黄斑部视网膜前膜.北京:北京医科大学中国协和医科大学联合出版社1996:131-135.
  • 6Spin MJ. Comparison of 25,23 and 20- gauge vitrectomy. Curr Opin Ophthalmol 2009 ; 20 : 195 - 199.
  • 7Smiddy WE ,Michels RG, Green WR. Morphology ,pathology ,and surgery of idiopathic vitreoretinal macular disorders [ J ]. Reti- na,1990,10 (4) :298-296.
  • 8Saran BR, Brucker AJ. Macular epiretinal membrane formation and treated retinal breaks [ J ].Am J Ophthalmol, 1995,120 ( 4 ) : 480-485.
  • 9Pournaras CJ,Emarah A,Petropoulos Ⅱ Idiopathic macular epiret- inal membrane surgery and ILM peeling: anatomical and func- tional outcomes [ J]. Semin Ophthalmol, 2011,26 ( 2 ) :42-46.
  • 10Konstantinidis LI, Berguiga M, Beknazar E, Wolfensberger TJ. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathicmacular epiretinal membrane [ J ]. Retina ,2009,29 ( 8 ) : 1119-1127.

引证文献11

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部